• hCG, H3K27 Methylation, and CXCL10 in Decidua

  2026-09-18

  The reference study shows that human chorionic gonadotropin suppresses decidual CXCL10 through EZH2-dependent deposition of the repressive H3K27me3 mark at the CXCL10 promoter. This work connects placental hormone signaling with chromatin-based control of CD8 T-cell recruitment and provides a mechanistic framework for studying immune adaptation at the maternal–fetal interface.

• Toremifene vs Tamoxifen: Cochrane Evidence

  2026-09-17

  This Cochrane review synthesized randomized evidence comparing toremifene with tamoxifen in advanced breast cancer. It found no convincing difference in tumor response, time to progression, or overall survival, while selected adverse-event patterns may still inform individualized treatment decisions and translational study design.

• RIPostC, Ketone Bodies, and Ferroptosis After Stroke

  2026-09-17

  A 2024 ACS Chemical Neuroscience study identifies ketone body production as a mechanistic link between remote ischemic postconditioning and reduced ferroptotic injury after ischemic stroke. Its rat and HT22-cell experiments connect metabolic recovery with GPX4 preservation, ACSL4 suppression, improved mitochondrial structure, and reduced iron accumulation, providing a framework for testing 3-hydroxybutyrate and related ketone bodies in neuroprotection research.

• 3X FLAG Peptide: From Tag to Translational Tool

  2026-09-16

  A mechanistic and strategic guide to using the 3X (DYKDDDDK) Peptide in recombinant protein purification, immunodetection, structural biology, and translational assay development, with human SPFH complexes as an architecture-aware case study.

• SMPD4, Ceramide, and Primary Cilia in Brain Development

  2026-09-16

  The 2024 Development study establishes SMPD4-dependent ceramide production as a mechanistic link between sphingolipid metabolism, primary-cilium formation, neural progenitor survival, and brain development. By combining a mouse model with human SMPD4-deficient induced pluripotent stem cells and a ceramide-rescue experiment, the work connects SMPD4 loss to cerebellar hypoplasia, microcephaly-related phenotypes, and developmental brain disease.

• Oxaliplatin Workflows for DNA-Damage Research

  2026-09-15

  Build reproducible Oxaliplatin assays for DNA adduct formation, apoptosis, drug resistance, and tumor-model response. This practical guide combines solution handling, cell-based dose finding, mechanistic controls, and ABCB1-focused readouts to distinguish cytotoxicity from altered drug transport.

• Müller Cell PEDF Controls Retinal Neuron Survival

  2026-09-15

  The 2026 study by Younis and colleagues identifies Müller cells as an essential intermediary in angiopoietin-regulated retinal neuron survival. Its experiments connect Ang-1 and Ang-2 activity with Müller cell Tie-2/PI3K/Akt signaling, PEDF production, and PEDF-receptor-dependent neuronal protection, providing a mechanistic framework for retinal neurovascular research.

• Dasatinib Monohydrate Assay Guide

  2026-09-14

  Learn how Dasatinib Monohydrate, SKU B5954, can support reproducible kinase-inhibitor studies across viability, proliferation, cytotoxicity, and CML models. This scenario-based guide connects product formulation data with practical controls, concentration-response design, NET-related interpretation, and vendor-selection criteria.

• Decitabine as a Causality Probe in Gastric Cancer

  2026-09-14

  Decitabine (5-Aza-2'-deoxycytidine) can do more than reduce DNA methylation: it can help test whether infection-associated silencing of HNF4A is functionally linked to gastric cancer progression. This article presents a causality-focused framework for cancer epigenetics, tumor suppressor gene reactivation, and solid tumor epigenetic studies.

• SIRT1–PGC-1α–TFAM Signaling in Prion Stress

  2026-09-13

  Zhao et al. show that prion peptide-induced mitochondrial injury in N2a cells is associated with reduced SIRT1 abundance and activity, impaired mitochondrial biogenesis, and apoptosis. The study identifies a SIRT1–PGC-1α–TFAM pathway through which SIRT1 activation, including pharmacological activation by Resveratrol, can restore mitochondrial function in this cellular model.

• NADH as a Redox Decision Point in Cell Research

  2026-09-12

  NADH is more than an energy-transfer coenzyme: its relationship with NAD⁺ provides a framework for interpreting mitochondrial, metabolic, and disease-model data. This article translates NADH redox biology into practical assay decisions, controls, and research applications.

• Concanavalin A Targets Conserved Coronavirus Glycans

  2026-09-11

  Guo and colleagues identify two phylogenetically conserved high-mannose N-glycans near the coronavirus spike S2′ cleavage site as a broad antiviral vulnerability for concanavalin A. By combining fusion, pseudovirus, authentic-virus, biochemical, and mouse studies, the work links glycan recognition to impaired spike activation rather than rapidly evolving receptor-binding epitopes.

• CLK2 Drives Platinum Resistance in Ovarian Cancer

  2026-09-11

  A 2024 study identifies CLK2 as a functional determinant of platinum resistance in ovarian cancer, linking CLK2 activity to BRCA1 Ser1423 phosphorylation and enhanced DNA damage repair. The findings establish a preclinical rationale for investigating CLK2-directed strategies while highlighting the need to distinguish CLK2 biology from broader Cdc2-like kinase and splicing effects.

• Ibrutinib (PCI-32765): BTK Assay Design Guide

  2026-09-10

  Explore how Ibrutinib (PCI-32765) converts BTK biology into rigorous B-cell assays, from covalent pathway inhibition to CLL and autoimmune disease models. This guide also extracts transferable assay-design lessons from an Alzheimer’s disease study without conflating its findings with BTK pharmacology.

• Decitabine and HNF4A: Mapping Epigenetic Rescue

  2026-09-10

  Decitabine (5-Aza-2'-deoxycytidine) can do more than reduce methylation globally. This article shows how to use infection-linked HNF4A silencing as a model for designing locus-aware cancer epigenetics experiments and distinguishing tumor suppressor gene reactivation from nonspecific cytotoxicity.

7990 records 1/533 page Next 12345 下5页 Last page